JONBUR Research · Initiation
You're reading an earlier report from Oct 13, 2026. See the latest report
Yuhan · 000100 · Biotech & Pharma
Yuhan: Profits Recover From a Low Base as the Shares Fall 40.3% Over One Year
Yuhan's share price closed at ₩72,000 on 2026-10-12, down 40.3% over one year and 9.3% over one month, while trailing revenue reached ₩2.3T. Operating margin has improved to 5.4% from 2.7% in 2024, but net profit is well above operating profit and free cash flow is thin.
Written Oct 13, 2026 · Data as of Oct 12, 2026 · 0 views
This is not financial advice. The report does not recommend buying or selling anything.
Thesis
The data supports a picture of steady sales growth and improving profitability from a low base. Revenue has grown every year shown, from ₩1.7T in 2021 to ₩2.2T in 2025, and trailing twelve-month (TTM) revenue to H1 2026 is ₩2.3T. Operating income rose from ₩54.9B in 2024 to ₩104.4B in 2025, and the TTM figure is ₩123.8B.
The data does not fully support a clean earnings-quality story. TTM net income of ₩237.1B is almost double operating income, which suggests non-operating gains contribute meaningfully, though the data does not say what they are. Free cash flow is only ₩27.0B. The share price is 44.3% below its 52-week high of ₩129,200 and 10.8% above its low of ₩65,000. The reasons for the decline are not in the data, and no news headlines are available.
Business overview
Yuhan is a KOSPI-listed company in the Biotech & Pharma sector, founded on 1926-06-20 and listed on 1962-11-01. The CEO is listed as 조욱제. It has 79,968,437 listed shares and a market capitalisation of about ₩5.8T.
Revenue grew from ₩1,687.8B in 2021 to ₩2,186.6B in 2025. Annual growth was 5.2% in 2022, 4.7% in 2023, 11.2% in 2024 and 5.7% in 2025. The data does not break revenue down by product or segment.
Every earlier JONBUR Research report and update note on Yuhan, with Pro.
Unlock with ProModel estimate of fair value
The valuation model has no estimate for this company yet (not enough data, or no positive value with the base case).
Report history
- Oct 28, 2026Update noteEarningsYuhan Q3 2026 Preliminary Results: Operating Profit Up 44.2% but Down 43.4% From Q2
- Oct 20, 2026Update noteBig price moveYuhan Shares Rise 21.4% in Five Trading Days on Heavy Volume
- Oct 13, 2026InitiationYuhan: Profits Recover From a Low Base as the Shares Fall 40.3% Over One Year
Source: KRX statistical information